MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan

By: via Benzinga
ALK (OTC: AKABY) today announced that the sublingual allergy immunotherapy product MITICURE now will be available for prescription in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.